Is Celgene a Buffett Stock?

Is Celgene a Buffett Stock?


Remarkably, this figure is actually up since the start of the year, even though Berkshire recently acquired Precision Castparts for $37.2 billion. That invites the question: What other companies could Buffett have his eye on right now? While there is no telling what other companies the Oracle of Omaha could be eyeing at the moment, we can use the acquisition criteria that he lays out in his annual letter to shareholders to determine whether a stock might interest him.



from Biotech News